Prime works to simplify medication management and support patients with migraine, making migraine treatment less of a pain point

Prime Therapeutics offers innovative medication management solutions, supports patients with chronic conditions

The SIU promotes safety to prevent fraud, waste and abuse schemes

Lead author David Eckwright shares more about the study “Real-World Extended Dosing Assessment for Eye(s) new to Faricimab-svoa Therapy.”

Dinesh Kandanchatha joined the organization July 1.

A strategic deep dive into the latest trend report from Prime Therapeutics reveals how oncology spend is evolving across benefits and what it means for cancer care management

Cover image for FDA Decisions Expected_February 2025 Drug pipeline for February 2025 Prime Therapeutics /fda-decisions-expected-february-2025 About Prime Therapeutics Prime Therapeutics logo Prime...

Event features Pat Gleason, AVP, health outcomes at Prime Therapeutics

Cover image for FDA Decisions Expected: November 2024 Drug pipeline for November 2024 Prime Therapeutics /fda-decisions-expected-november-2024 Prime Therapeutics’ FDA Decisions Expected outlines...

Cover AMCP Prime Therapeutics /amcp-nexus-2024-research-posters 10 research posters presented by Prime at AMCP Nexus 2024 covers topics like GLP-1 obesity research, health equity initiatives, and...